Pancreatic Cancer Research

ResearcherMassachusetts General HospitalNo recent work listed

Edmund J. Keliher

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6607-0760; OpenAlex author ID A5064312956. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: 1 paper

Papers 2

  1. The use of 18F-2-fluorodeoxyglucose (FDG) to label antibody fragments for immuno-PET of pancreatic cancer. First author DOI 10.1021/acscentsci.5b00121↗
  2. Targeting cathepsin E in pancreatic cancer by a small molecule allows in vivo detection. Co-author DOI 10.1593/neo.13276↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ralph Weissleder · 2 shared papers, 2013–2015 · strength 0.08
  2. Michael Lawrence Dougan · 1 shared paper, 2015 · strength 0.05
  3. Hidde L. Ploegh · 1 shared paper, 2015 · strength 0.05
  4. Mohammad Rashidian · 1 shared paper, 2015 · strength 0.05
  5. Douglas Hanahan · 1 shared paper, 2013 · strength 0.03
  6. Ronald Anthony Depinho · 1 shared paper, 2013 · strength 0.03
  7. Nabeel M. Bardeesy · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.